Direct Implantation of Rapamycin-Eluting Stents with Bioresorbable Drug Carrier Technology Utilizing the Svelte Coronary Stent-on-a-Wire: 2-Year Follow-Up of the Randomized, Controlled DIRECT II Study

Verheye, Stefan; Stella, Pieter; Carrie, Didier; Khattab, Ahmed; Slagboom, Ton; Bartunek, Jozef

doi:https://doi.org/10.1016/j.jacc.2016.09.592

Direct Implantation of Rapamycin-Eluting Stents with Bioresorbable Drug Carrier Technology Utilizing the Svelte Coronary Stent-on-a-Wire: 2-Year Follow-Up of the Randomized, Controlled DIRECT II Study

DSpace/Manakin Repository

Direct Implantation of Rapamycin-Eluting Stents with Bioresorbable Drug Carrier Technology Utilizing the Svelte Coronary Stent-on-a-Wire: 2-Year Follow-Up of the Randomized, Controlled DIRECT II Study

Verheye, Stefan; Stella, Pieter; Carrie, Didier; Khattab, Ahmed; Slagboom, Ton; Bartunek, Jozef

(2016) Journal of the American College of Cardiology, volume 68, issue 18, Suppl. 1, pp. B183 - B184

(Abstract)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

DOI: https://doi.org/10.1016/j.jacc.2016.09.592

ISSN: 0735-1097

Publisher: Elsevier USA

Note: Twenty-Eighth Annual Symposium Transcatheter Cardiovascular Therapeutics (TCT)–Abstracts